vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Smith Douglas Homes Corp. (SDHC). Click either name above to swap in a different company.
Smith Douglas Homes Corp. is the larger business by last-quarter revenue ($260.4M vs $196.0M, roughly 1.3× Axsome Therapeutics, Inc.). Smith Douglas Homes Corp. runs the higher net margin — 1.4% vs -14.6%, a 15.9% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -9.4%). Smith Douglas Homes Corp. produced more free cash flow last quarter ($8.7M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 17.3%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
AXSM vs SDHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $260.4M |
| Net Profit | $-28.6M | $3.5M |
| Gross Margin | — | 19.9% |
| Operating Margin | -13.8% | 6.5% |
| Net Margin | -14.6% | 1.4% |
| Revenue YoY | 65.0% | -9.4% |
| Net Profit YoY | 61.9% | -14.3% |
| EPS (diluted) | $-0.55 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $260.4M | ||
| Q3 25 | $171.0M | $262.0M | ||
| Q2 25 | $150.0M | $223.9M | ||
| Q1 25 | $121.5M | $224.7M | ||
| Q4 24 | $118.8M | $287.5M | ||
| Q3 24 | $104.8M | $277.8M | ||
| Q2 24 | $87.2M | $220.9M | ||
| Q1 24 | $75.0M | $189.2M |
| Q4 25 | $-28.6M | $3.5M | ||
| Q3 25 | $-47.2M | $2.1M | ||
| Q2 25 | $-48.0M | $2.4M | ||
| Q1 25 | $-59.4M | $2.7M | ||
| Q4 24 | $-74.9M | $4.1M | ||
| Q3 24 | $-64.6M | $5.3M | ||
| Q2 24 | $-79.3M | $3.6M | ||
| Q1 24 | $-68.4M | $3.0M |
| Q4 25 | — | 19.9% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | — | 23.2% | ||
| Q1 25 | — | 23.8% | ||
| Q4 24 | — | 25.5% | ||
| Q3 24 | — | 26.5% | ||
| Q2 24 | — | 26.7% | ||
| Q1 24 | — | 26.1% |
| Q4 25 | -13.8% | 6.5% | ||
| Q3 25 | -27.0% | 6.6% | ||
| Q2 25 | -24.5% | 7.7% | ||
| Q1 25 | -46.9% | 8.7% | ||
| Q4 24 | -61.1% | 10.4% | ||
| Q3 24 | -59.8% | 14.2% | ||
| Q2 24 | -89.5% | 11.7% | ||
| Q1 24 | -89.7% | 11.3% |
| Q4 25 | -14.6% | 1.4% | ||
| Q3 25 | -27.6% | 0.8% | ||
| Q2 25 | -32.0% | 1.1% | ||
| Q1 25 | -48.9% | 1.2% | ||
| Q4 24 | -63.1% | 1.4% | ||
| Q3 24 | -61.7% | 1.9% | ||
| Q2 24 | -91.0% | 1.7% | ||
| Q1 24 | -91.1% | 1.6% |
| Q4 25 | $-0.55 | $0.39 | ||
| Q3 25 | $-0.94 | $0.24 | ||
| Q2 25 | $-0.97 | $0.26 | ||
| Q1 25 | $-1.22 | $0.30 | ||
| Q4 24 | $-1.54 | $0.50 | ||
| Q3 24 | $-1.34 | $0.58 | ||
| Q2 24 | $-1.67 | $0.40 | ||
| Q1 24 | $-1.44 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $12.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $86.7M |
| Total Assets | $689.8M | $557.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $12.7M | ||
| Q3 25 | $325.3M | $14.8M | ||
| Q2 25 | $303.0M | $16.8M | ||
| Q1 25 | $300.9M | $12.7M | ||
| Q4 24 | $315.4M | $22.4M | ||
| Q3 24 | $327.3M | $23.7M | ||
| Q2 24 | $315.7M | $17.3M | ||
| Q1 24 | $331.4M | $32.8M |
| Q4 25 | $88.3M | $86.7M | ||
| Q3 25 | $73.7M | $82.2M | ||
| Q2 25 | $73.1M | $80.0M | ||
| Q1 25 | $53.2M | $76.9M | ||
| Q4 24 | $57.0M | $73.6M | ||
| Q3 24 | $92.9M | $68.4M | ||
| Q2 24 | $102.9M | $62.1M | ||
| Q1 24 | $144.0M | $59.7M |
| Q4 25 | $689.8M | $557.6M | ||
| Q3 25 | $669.3M | $571.6M | ||
| Q2 25 | $639.8M | $570.2M | ||
| Q1 25 | $596.7M | $513.9M | ||
| Q4 24 | $568.5M | $475.9M | ||
| Q3 24 | $561.5M | $460.1M | ||
| Q2 24 | $548.2M | $429.3M | ||
| Q1 24 | $545.7M | $401.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $9.8M |
| Free Cash FlowOCF − Capex | $-18.7M | $8.7M |
| FCF MarginFCF / Revenue | -9.6% | 3.4% |
| Capex IntensityCapex / Revenue | 0.0% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 2.77× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $-36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $9.8M | ||
| Q3 25 | $1.0M | $22.8M | ||
| Q2 25 | $-32.4M | $-28.9M | ||
| Q1 25 | $-43.4M | $-34.9M | ||
| Q4 24 | $-26.2M | $5.5M | ||
| Q3 24 | $-18.6M | $22.9M | ||
| Q2 24 | $-30.1M | $39.0K | ||
| Q1 24 | $-53.5M | $-9.3M |
| Q4 25 | $-18.7M | $8.7M | ||
| Q3 25 | $988.0K | $21.4M | ||
| Q2 25 | $-32.4M | $-31.1M | ||
| Q1 25 | $-43.7M | $-35.9M | ||
| Q4 24 | $-26.2M | $4.8M | ||
| Q3 24 | $-18.7M | $22.3M | ||
| Q2 24 | $-30.2M | $-2.1M | ||
| Q1 24 | $-53.6M | $-9.7M |
| Q4 25 | -9.6% | 3.4% | ||
| Q3 25 | 0.6% | 8.2% | ||
| Q2 25 | -21.6% | -13.9% | ||
| Q1 25 | -36.0% | -16.0% | ||
| Q4 24 | -22.1% | 1.7% | ||
| Q3 24 | -17.9% | 8.0% | ||
| Q2 24 | -34.6% | -1.0% | ||
| Q1 24 | -71.4% | -5.1% |
| Q4 25 | 0.0% | 0.4% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.3% | 0.5% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.1% | 0.2% | ||
| Q2 24 | 0.1% | 1.0% | ||
| Q1 24 | 0.1% | 0.2% |
| Q4 25 | — | 2.77× | ||
| Q3 25 | — | 10.70× | ||
| Q2 25 | — | -12.24× | ||
| Q1 25 | — | -13.01× | ||
| Q4 24 | — | 1.33× | ||
| Q3 24 | — | 4.28× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | -3.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
SDHC
| Southeast | $164.7M | 63% |
| Central | $95.8M | 37% |
